Suppr超能文献

肝移植受者移植后早期新蝶呤与一年生存率及菌血症相关。

Early post-transplant neopterin associated with one year survival and bacteremia in liver transplant recipients.

作者信息

Oweira Hani, Lahdou Imad, Daniel Volker, Hofer Stefan, Mieth Markus, Schmidt Jan, Schemmer Peter, Opelz Gerhard, Mehrabi Arianeb, Sadeghi Mahmoud

机构信息

Department of General, Visceral and Transplant Surgery, University of Heidelberg, Heidelberg, Germany; Vascular and Visceral Surgery Center, Kappelistrasse 7, 8002 Zürich, Switzerland.

Department Transplantation Immunology, University of Heidelberg, Germany.

出版信息

Hum Immunol. 2016 Jan;77(1):115-120. doi: 10.1016/j.humimm.2015.11.003. Epub 2015 Nov 12.

Abstract

Bacterial infections are the most common complications, and the major cause of mortality after liver transplantation (Tx). Neopterin, a marker of immune activation, is produced in monocyte/macrophages in response to inflammation. The aim of our study was to investigate whether early post-operation serum levels of neopterin were associated with post-transplant bacteremia and mortality in liver transplant recipients. We studied 162 of 262 liver Tx patients between January 2008 and February 2011 of whom pre- and early post-Tx sera samples were available. Pre- and early post-operative risk factors of infection and mortality were evaluated in 45 bacteremic patients and 117 non-bacteremic patients. During one-year follow-up, 28 of 262 patients died because of graft failure, septicemia and other diseases. Post-Tx serum neopterin on day 10 (p<0.001) were significantly higher in bacteriemic patients than in patients without bacteremia. Logistic regression analyses showed that day 10 post-Tx neopterin serum level ⩾40 nmol/l has a predictive value (OR=6.86: p<0.001) for bacteremia and mortality (OR=3.47: p=0.021). Our results suggest that early post-Tx neopterin serum levels are very sensitive predictive markers of one-year post-Tx bacteremia and mortality in liver Tx recipients.

摘要

细菌感染是肝移植术后最常见的并发症,也是导致死亡的主要原因。新蝶呤是一种免疫激活标志物,由单核细胞/巨噬细胞在炎症反应中产生。我们研究的目的是调查肝移植受者术后早期血清新蝶呤水平是否与移植后菌血症及死亡率相关。我们研究了2008年1月至2011年2月期间262例肝移植患者中的162例,这些患者术前及术后早期的血清样本均可用。对45例菌血症患者和117例非菌血症患者的术前及术后早期感染和死亡的危险因素进行了评估。在一年的随访期间,262例患者中有28例因移植失败、败血症及其他疾病死亡。菌血症患者术后第10天的血清新蝶呤水平(p<0.001)显著高于无菌血症的患者。逻辑回归分析显示,术后第10天血清新蝶呤水平⩾40 nmol/l对菌血症及死亡率具有预测价值(OR=6.86:p<0.001)(OR=3.47:p=0.021)。我们的结果表明,肝移植受者术后早期血清新蝶呤水平是移植后一年菌血症及死亡率非常敏感的预测指标。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验